Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...

Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

HeartBeam’s ECG software duplicates the 12-lead ECG approach undertaken in healthcare settings with electrodes to evaluate ...

A new Concordia study published in npj Biomedical Innovations suggests that a simple 30-second electrocardiogram (ECG) ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...

The Apple Watch's electrocardiogram feature, along with other health indicators, can act as a basic stress detector. A new study shows the device is useful for indicating stress due to a range of ...

Correspondence to Ricardo Stein, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil; rstein{at}cardiol.br Objectives To evaluate the prevalence of abnormal ECG findings and ...

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence ...

The electrocardiogram test commonly given to people suspected of having cramping chest pains from angina have limited value when it comes to predicting future heart problems, a new study suggests.